---
figid: PMC10136927__cells-12-01110-g003
figtitle: Targeting Wnt signaling pathway by the latest technologies
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10136927
filename: PMC10136927__cells-12-01110-g003.jpg
figlink: /pmc/articles/PMC10136927/figure/F3
number: F3
caption: Targeting Wnt signaling pathway by the latest technologies. β-catenin targeted
  PROTACs (xStAx-VHL) recruits E3 ligase to β-catenin, inducing the degradation of
  β-catenin using the ubiquitin–proteasome system. Additionally, the molecular glue
  of β-catenin and its E3 ligase β-TrCP, NRX-252114, enhances the β-catenin degradation.
  ADCs (LGR5-mc-vc-PAB-MMAE, LRG5-NMs818, and PF-06647020) targeting LGR5- or PTK7-expressing
  Wnt responder cells bind to the target cells and release a cytotoxic drug to induce
  the cell death. ASO (LNA-modified ASO, β-catenin targeting ASO) binds to the target
  region of RNA and suppresses expression.
papertitle: 'A New Wave of Targeting ‘Undruggable’ Wnt Signaling for Cancer Therapy:
  Challenges and Opportunities'
reftext: Woo-Jung Park, et al. Cells. 2023 Apr;12(8).
year: '2023'
doi: 10.3390/cells12081110
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: MDPI
keywords: Wnt signaling | β-catenin | targeted cancer therapy | PROTAC | antibody–drug
  conjugate (ADC) | anti-sense oligonucleotide (ASO)
automl_pathway: 0.9521861
figid_alias: PMC10136927__F3
figtype: Figure
redirect_from: /figures/PMC10136927__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10136927__cells-12-01110-g003.html
  '@type': Dataset
  description: Targeting Wnt signaling pathway by the latest technologies. β-catenin
    targeted PROTACs (xStAx-VHL) recruits E3 ligase to β-catenin, inducing the degradation
    of β-catenin using the ubiquitin–proteasome system. Additionally, the molecular
    glue of β-catenin and its E3 ligase β-TrCP, NRX-252114, enhances the β-catenin
    degradation. ADCs (LGR5-mc-vc-PAB-MMAE, LRG5-NMs818, and PF-06647020) targeting
    LGR5- or PTK7-expressing Wnt responder cells bind to the target cells and release
    a cytotoxic drug to induce the cell death. ASO (LNA-modified ASO, β-catenin targeting
    ASO) binds to the target region of RNA and suppresses expression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AZIN2
  - GADL1
  - LGR5
  - FZD7
  - LRP5
  - LRP6
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - ZNRF3
  - RNF43
  - PTK7
  - AXIN1
  - AXIN2
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - GSK3A
  - GSK3B
  - APC
  - PROC
  - BTRC
  - CTNNB1
  - EP300
  - HNF4A
  - ADC
  - Nucleus
  - Cancer
---
